Recent biochemical studies have shown that the cytoplasmic islet cell–antibody autoantigen has properties of a monosialoganglioside (GM). To characterize islet glycolipids and ascertain whether islets express unique gangliosides, we determined the pattern of ganglioside expression in whole human pancreas and isolated human islets using high-performance liquid chromatography (HPLC) and high-performance thin-layer chromatography (HPTLC). The major gangliosides detected in glycolipid extracts of whole human pancreas were GM3, GD3 (disialoganglioside), and in a lesser amount, a GD1a-comigrating ganglioside. In contrast to whole human pancreas, isolated human islets were found to predominantly express GM3, an acidic glycolipid comigrating with GM2, and a ganglioside with mobility between GM2 and GM1 by both HPLC and HPTLC. Quantitation of the major ganglioside UV peaks seen on HPLC gave the following results. In whole pancreas, GM3 represented 66.7% of total gangliosides detected; an asialoglycolipid comigrating with GM2, 2.0%; a ganglioside migrating between GM2 and GM1, 2.6%; GD3, 22.6%; and a GD1a-comigrating ganglioside, 6.1%. In isolated islets, these components were found at the following levels: GM3, 14.9%; GM2-comigrating glycolipid, 74.2%; a ganglioside migrating between GM2 and GM1, 9.8%; GD3, 1.1%; and the GD1a-comigrating ganglioside, not detectable.
Skip Nav Destination
Article navigation
Original Articles|
November 01 1989
Ganglioside Expression in Human Pancreatic Islets
Francesco Dotta;
Francesco Dotta
Joslin Diabetes Center, Brigham and Women's Hospital, and Harvard Medical School
Boston, Massachusetts
Clinica Medica 2/Endocrinologia 1, and the Department of Experimental Medicine, University of Rome
Italy
Department of Surgery, Washington University School of Medicine
St. Louis, Missouri
Search for other works by this author on:
Peter G Colman;
Peter G Colman
Joslin Diabetes Center, Brigham and Women's Hospital, and Harvard Medical School
Boston, Massachusetts
Clinica Medica 2/Endocrinologia 1, and the Department of Experimental Medicine, University of Rome
Italy
Department of Surgery, Washington University School of Medicine
St. Louis, Missouri
Search for other works by this author on:
Daniela Lombardi;
Daniela Lombardi
Joslin Diabetes Center, Brigham and Women's Hospital, and Harvard Medical School
Boston, Massachusetts
Clinica Medica 2/Endocrinologia 1, and the Department of Experimental Medicine, University of Rome
Italy
Department of Surgery, Washington University School of Medicine
St. Louis, Missouri
Search for other works by this author on:
David W Scharp;
David W Scharp
Joslin Diabetes Center, Brigham and Women's Hospital, and Harvard Medical School
Boston, Massachusetts
Clinica Medica 2/Endocrinologia 1, and the Department of Experimental Medicine, University of Rome
Italy
Department of Surgery, Washington University School of Medicine
St. Louis, Missouri
Search for other works by this author on:
Domenico Andreani;
Domenico Andreani
Joslin Diabetes Center, Brigham and Women's Hospital, and Harvard Medical School
Boston, Massachusetts
Clinica Medica 2/Endocrinologia 1, and the Department of Experimental Medicine, University of Rome
Italy
Department of Surgery, Washington University School of Medicine
St. Louis, Missouri
Search for other works by this author on:
Giuseppe M Pontieri;
Giuseppe M Pontieri
Joslin Diabetes Center, Brigham and Women's Hospital, and Harvard Medical School
Boston, Massachusetts
Clinica Medica 2/Endocrinologia 1, and the Department of Experimental Medicine, University of Rome
Italy
Department of Surgery, Washington University School of Medicine
St. Louis, Missouri
Search for other works by this author on:
Umberto Di Mario;
Umberto Di Mario
Joslin Diabetes Center, Brigham and Women's Hospital, and Harvard Medical School
Boston, Massachusetts
Clinica Medica 2/Endocrinologia 1, and the Department of Experimental Medicine, University of Rome
Italy
Department of Surgery, Washington University School of Medicine
St. Louis, Missouri
Search for other works by this author on:
Luisa Lenti;
Luisa Lenti
Joslin Diabetes Center, Brigham and Women's Hospital, and Harvard Medical School
Boston, Massachusetts
Clinica Medica 2/Endocrinologia 1, and the Department of Experimental Medicine, University of Rome
Italy
Department of Surgery, Washington University School of Medicine
St. Louis, Missouri
Search for other works by this author on:
George S Eisenbarth;
George S Eisenbarth
Joslin Diabetes Center, Brigham and Women's Hospital, and Harvard Medical School
Boston, Massachusetts
Clinica Medica 2/Endocrinologia 1, and the Department of Experimental Medicine, University of Rome
Italy
Department of Surgery, Washington University School of Medicine
St. Louis, Missouri
Search for other works by this author on:
Ramesh C Nayak
Ramesh C Nayak
Joslin Diabetes Center, Brigham and Women's Hospital, and Harvard Medical School
Boston, Massachusetts
Clinica Medica 2/Endocrinologia 1, and the Department of Experimental Medicine, University of Rome
Italy
Department of Surgery, Washington University School of Medicine
St. Louis, Missouri
Search for other works by this author on:
Address correspondence and reprint requests to Francesco Dotta, MD, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215.
Diabetes 1989;38(11):1478–1483
Article history
Received:
January 18 1989
Revision Received:
July 06 1989
Accepted:
July 06 1989
PubMed:
2695376
Citation
Francesco Dotta, Peter G Colman, Daniela Lombardi, David W Scharp, Domenico Andreani, Giuseppe M Pontieri, Umberto Di Mario, Luisa Lenti, George S Eisenbarth, Ramesh C Nayak; Ganglioside Expression in Human Pancreatic Islets. Diabetes 1 November 1989; 38 (11): 1478–1483. https://doi.org/10.2337/diab.38.11.1478
Download citation file:
102
Views